197 related articles for article (PubMed ID: 10435158)
21. Stromelysin-3 expression is an early event in human oral tumorigenesis.
Soni S; Mathur M; Shukla NK; Deo SV; Ralhan R
Int J Cancer; 2003 Nov; 107(2):309-16. PubMed ID: 12949813
[TBL] [Abstract][Full Text] [Related]
22. [P53 expression and clinical significance in oral squamous cell carcinoma].
Long Y; Ling D; Yue W
Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
[TBL] [Abstract][Full Text] [Related]
23. A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma.
Gorgoulis VG; Zoumpourlis V; Rassidakis GZ; Karameris A; Rassidakis AN; Spandidos DA; Kittas C
J Pathol; 1996 Oct; 180(2):129-37. PubMed ID: 8976869
[TBL] [Abstract][Full Text] [Related]
24. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
25. Expression of p53, epidermal growth factor receptor, c-erbB2 in oral leukoplakias and oral squamous cell carcinomas.
Singla S; Singla G; Zaheer S; Rawat DS; Mandal AK
J Cancer Res Ther; 2018; 14(2):388-393. PubMed ID: 29516925
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma.
Sano T; Hikino T; Xue Q; Saito T; Kashiwabara K; Oyama T; Nakajima T
Pathol Int; 2000 Sep; 50(9):709-16. PubMed ID: 11012984
[TBL] [Abstract][Full Text] [Related]
27. Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India.
Teni T; Pawar S; Sanghvi V; Saranath D
Pathol Oncol Res; 2002; 8(2):109-14. PubMed ID: 12172574
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of p53 in non-malignant and malignant oral lesions associated with snuff dipping in the Sudan and Sweden.
Ibrahim SO; Johannessen AC; Idris AM; Hirsch JM; Vasstrand EN; Magnusson B; Nilsen R
Int J Cancer; 1996 Dec; 68(6):749-53. PubMed ID: 8980178
[TBL] [Abstract][Full Text] [Related]
29. MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S; Takami K; Nakayama T; Nishisho I
Br J Cancer; 1997; 75(9):1302-8. PubMed ID: 9155050
[TBL] [Abstract][Full Text] [Related]
30. Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
Ralhan R; Nath N; Agarwal S; Mathur M; Wasylyk B; Shukla NK
Clin Cancer Res; 1998 Sep; 4(9):2147-52. PubMed ID: 9748133
[TBL] [Abstract][Full Text] [Related]
31. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
[TBL] [Abstract][Full Text] [Related]
32. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: relationship with cell cycle regulators.
Ralhan R; Chakravarti N; Kaur J; Sharma C; Kumar A; Mathur M; Bahadur S; Shukla NK; Deo SV
Int J Cancer; 2006 Mar; 118(5):1077-89. PubMed ID: 16161051
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
Fan GK; Chen J; Ping F; Geng Y
Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
[TBL] [Abstract][Full Text] [Related]
35. Detection of p53 and MDM2 protein expression in head and neck carcinogenesis.
Girod SC; Cesarz D; Fischer U; Krueger GR
Anticancer Res; 1995; 15(4):1453-7. PubMed ID: 7654034
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of expression of p53 oncoprotein in oral carcinomas from India associated with betel and tobacco chewing.
Kuttan NA; Rosin MP; Ambika K; Priddy RW; Bhakthan NM; Zhang L
Eur J Cancer B Oral Oncol; 1995 May; 31B(3):169-73. PubMed ID: 7549756
[TBL] [Abstract][Full Text] [Related]
37. Alterations in MDM2 expression in esophageal squamous cell carcinoma: relationship with p53 status.
Arora S; Mathew R; Mathur M; Chattopadhayay TK; Ralhan R
Pathol Oncol Res; 2001; 7(3):203-8. PubMed ID: 11692147
[TBL] [Abstract][Full Text] [Related]
38. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
Nylander K; Dabelsteen E; Hall PA
J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
[TBL] [Abstract][Full Text] [Related]
39. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation.
Pruneri G; Pignataro L; Carboni N; Luminari S; Capaccio P; Neri A; Buffa R
Mod Pathol; 1997 Aug; 10(8):785-92. PubMed ID: 9267820
[TBL] [Abstract][Full Text] [Related]
40. p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years.
Regezi JA; Dekker NP; McMillan A; Ramirez-Amador V; Meneses-Garcia A; Ruiz-Godoy Rivera LM; Chrysomali E; Ng IO
Oral Oncol; 1999 Jul; 35(4):379-83. PubMed ID: 10645402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
